Translational Autoimmunity, Volume 2

<p>1. Introduction on therapeutic opportunities for autoimmunity<br>2. Innate lymphoid cells as therapeutic targets in autoimmune diseases<br>3. B regulatory cells in patients with autoimmune diseases: pathogenic significance, therapeutic potential<br>4. Regulatory T cells in autoimmunity and potential therapeutic targets<br>5. Application of IL-6 antagonists in autoimmune disorders<br>6. The search for monomer interaction-based alternative TNFα therapies<br>7. Generation of thymic cells from pluripotent stem cells for basic research and cell therapy<br>8. The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?<br>9. Plasmocytes infiltrating autoimmune organs and their putative targeting<br>10. Biological aging and autoimmunity<br>11. Efficacy and safety of biologic treatment in autoimmune diseases<br>12. Nutritional implications for the pathophysiology and treatment of autoimmune disorders<br>13. Dysbiosis and probiotic applications in autoimmune diseases<br>14. Precision medicine in managing chronic conditions with an immunological component<br>15. New advanced therapy medicinal products in treatment of autoimmune diseases<br>16. Targeting of autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches<br>17. Immunomodulatory effects of parasites on autoimmunity<br>18. Prediction of autoimmune diseases: from bench to bedside</p>